Literature DB >> 19816185

Demographics of patients older than 50 years with keratoconus.

Elvin H Yildiz1, Guilherme F Diehl, Elisabeth J Cohen, Kristin M Hammersmith, Peter R Laibson, Christopher J Rapuano.   

Abstract

PURPOSE: This study was designed to determine the demographics of patients aged 50 years or more with a diagnosis of keratoconus, who were seen on the Cornea Service at Wills Eye Hospital.
METHODS: A retrospective chart review of all patients with the diagnosis of keratoconus was undertaken to identify demographics characteristics between January 1, 2005 and December 31, 2005.
RESULTS: A total of 697 patients were identified. Two hundred seventy-nine (40.0%) patients were age 50 years or more. The age ranged from 50 to 93 years (average 60.2 +/- 8.2 years). Keratoconus was diagnosed as a bilateral disease in 266 (95.3%) and as a unilateral disease in 13 patients (4.7%). In 186 patients (66.6% of the total), the average age at the time of diagnosis was 31.7 +/- 10.9 years (range from 13 to 70 years). Of the 279 patients, 167 had surgery (59.8%). In the group of 112 patients that did not have surgery, 25 (9.0%) were treated with glasses in both eyes, 85 (30.5%) with contact lenses in both eyes, and 2 (0.7%) with glasses in one eye and contact lenses in the other eye. The average time of follow-up was 13.6 +/- 10.5 years (range from 0.1 to 38.7 years).
CONCLUSIONS: In a corneal referral practice, the number of patients older than 50 years with keratoconus is higher than previously reported in the literature. We believe that this is because our practice has a strong interest in both contact lenses and corneal surgery with the ability to follow up patients on a long-term basis.

Entities:  

Mesh:

Year:  2009        PMID: 19816185     DOI: 10.1097/ICL.0b013e3181be5784

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  10 in total

1.  Bevel toric multicurve rigid gas-permeable lens for keratoconus.

Authors:  Ryoji Yanai; Kiichi Ueda; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2012-12-07       Impact factor: 2.447

2.  Two-stage procedure in the management of selected cases of keratoconus: clear lens extraction with aspherical IOL implantation followed by WFG-PRK.

Authors:  Waleed Abou Samra; Tharwat Mokbel; Mohammed Elwan; Sameh Saleh; Ahmed Elwehidy; Mohammed Iqbal; Adel Ellayeh
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  Corneal collagen cross-linking followed by phacoemulsification with IOL implantation for progressive keratoconus associated with high myopia and cataract.

Authors:  Leopoldo Spadea; Serena Salvatore; Francesca Verboschi; Enzo Maria Vingolo
Journal:  Int Ophthalmol       Date:  2015-08-08       Impact factor: 2.031

4.  Boston ocular surface prosthesis: an Indian experience.

Authors:  Varsha Madanlal Rathi; Preeji Sudharman Mandathara; Srikanth Dumpati; Pravin K Vaddavalli; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

Review 5.  The genetic and environmental factors for keratoconus.

Authors:  Ariela Gordon-Shaag; Michel Millodot; Einat Shneor; Yutao Liu
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

6.  Effect of ageing on keratoconic corneas.

Authors:  Michel Millodot; Ilya Ortenberg; Karen Lahav-Yacouel; Shmuel Behrman
Journal:  J Optom       Date:  2015-07-02

7.  Do age-related macular degeneration genes show association with keratoconus?

Authors:  Ke Cao; Srujana Sahebjada; Andrea J Richardson; Paul N Baird
Journal:  Eye Vis (Lond)       Date:  2019-12-01

8.  Transepithelial corneal collagen cross-linking in ultrathin keratoconic corneas.

Authors:  Leopoldo Spadea; Rita Mencucci
Journal:  Clin Ophthalmol       Date:  2012-11-02

9.  Keratoconus patients at Jordan University Hospital: a descriptive study.

Authors:  Mohammed A Abu Ameerh; Rola M Al Refai; Muawya D Al Bdour
Journal:  Clin Ophthalmol       Date:  2012-11-16

Review 10.  Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein.

Authors:  Rabab Sharif; Sashia Bak-Nielsen; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Prog Retin Eye Res       Date:  2018-07-13       Impact factor: 19.704

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.